CHRS Chart
- 52-Week Range: $7.45 - $18.99
- Market Capitalization: $612.42M
- Short Percentage: 0%
- Target Price: $22.50
- Shares Outstanding: 77.42M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CHRS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Coherus BioSciences Appoints Dr. Jill O'Donnell-Tormey to its Board of DirectorsGlobeNewsWire | May 11th
- Coherus BioSciences Management to Present at Upcoming Investor ConferencesGlobeNewsWire | May 10th
- Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q1 2022 Earnings Call TranscriptSeeking Alpha | May 5th
- CORRECTION - Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022GlobeNewsWire | April 29th
- Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022GlobeNewsWire | April 29th
- Coherus BioSciences Appoints Rosh Dias, MD, MRCP, Chief Medical OfficerGlobeNewsWire | March 15th
- Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 17th
- Coherus BioSciences Reports Fourth Quarter and Full Year 2021 ResultsGlobeNewsWire | February 17th
Company Info
Website: https://www.coherus.com
Address: 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065
Sector: Healthcare
Industry: Biotechnology
Full time employees: 332
Address: 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065
Sector: Healthcare
Industry: Biotechnology
Full time employees: 332
$CHRS Mindset is key
$CHRS I REALLY THINK WE FINALLY HAVE OUR FIRESALE?? !!
$CHRS Burn burn burn
$CHRS Overpower the algos!
$CHRS push baby push!
$CHRS market starting to dump
$CHRS glad I didn’t chase this isn’t moving anytime soon with all of those call options here lol
$CHRS looking ready to breakout soon.
$CHRS oversold
$CHRS buying time
added